Preprint paper on FenBen case studies

The results of the 3 case studies are similar to email updates Mr Makis publishes for cancer patients he consults. The interesting info here is the length of time the patients continue taking FenBen after reaching remission. That’s often a question his clients ask in their emails after having achieved good results with the protocol. As far as I can recall he’s never answered that question in his recap summary.

https://pmc.ncbi.nlm.nih.gov/articles/PMC12215191/

2 comments